Search results
Results from the WOW.Com Content Network
Large, high quality research has found small differences in the brain between ADHD and non-ADHD patients. [1] [15] Jonathan Leo and David Cohen, critics who reject the characterization of ADHD as a disorder, contended in 2003 and 2004 that the controls for stimulant medication usage were inadequate in some lobar volumetric studies, which makes it impossible to determine whether ADHD itself or ...
As many as 50,000 U.S. patients' access to treatment for attention deficit hyperactivity disorder could be disrupted after two executives at Done, a California-based telehealth company, were ...
Take Your Pills is an hour-long American documentary from 2018, directed by Alison Klayman and produced by Motto Pictures and Netflix Studios. The documentary explores the positives and negatives of taking psychostimulant medications such as Adderall.
He has donated to various charitable organizations and scientific research programs through the Bill & Melinda Gates Foundation, reported to be the world's largest private charity. Through the foundation, he led an early 21st century vaccination campaign that significantly contributed to the eradication of the wild poliovirus in Africa.
One in four U.S. adults suspects they may have ADHD and drugs are a first line of treatment for this condition. ... It found that people with ADHD who take prescription medication for this ...
Many of the ADHD medication shortages that have plagued the U.S. for the last two years have now been resolved, the Food and Drug Administration says. Yet some doctors and patients report they are ...
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...
(Reuters) -The U.S. Drug Enforcement Administration has increased the production limit for Takeda Pharmaceutical's ADHD drug Vyvanse and its generic versions by about 24% to address the ongoing ...